BED BATH & BEYOND, INC. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data BED BATH & BEYOND, INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	1,800	1,745	1,822	1,435	2,494	2,756	1,929	1,561	1,395	1,045
Cost of revenue	1,469	1,404	1,468	1,147	1,923	2,133	1,422	1,195	1,105	787
Gross profit	331	341	354	288	571	624	508	366	290	258
Selling and marketing	148	181	274	141	261	302	215	225	239	143
General and administrative	89.3	90.7	164	96.7	97.7	87.4	79.7	90.4	74.4	53.6
Operating expenses	324	387	571	350	475	513	481	510	474	319
Operating income	6.92	-46.6	-217	-62.4	96.7	111	27	-144	-184	-61.2
Interest expense	0.88	2.94	1.47	0.34	1.97	2.08	1.94	1.76
Interest income	0.33	0.66	2.21	1.8
Other non-operating income	13.6	-1.1	-2.75	-11	-5.07	12.5	-63.8	-134	-80.8	-27.6
Pre-tax income	20.5	-47.7	-220	-61.8	96.5	123	-33.9	-266	-258	-83.8
Income tax	9.3	64.2	-2.38	1.06	1.36	-48.8	1.38	41.7	0.68	0.83
Income from continuing operations				-62.9	95.1	172	-35.2	-308	-259
Net income to minority interests	-1.27	-2.04	-11.5	-12.9	-9.83
Net income	12.5	-110	-206	-122	56	389	-35.2	-308	-259	-84.6
EBITDA	34.2	-17.8	-186	-36.9	118	130	43.7	-125	-165	-44.9
EPS, basic	0.49	-4.28	-6.83	-3.46	1.25	8.18	-0.83	-6.81	-5.56	-1.41
EPS, diluted	0.49	-4.28	-6.83	-3.46	1.24	8.11	-0.83	-6.81	-5.56	-1.41
Shares, basic (weighted)	25.3	25	30	34.9	41.2	43	44.3	45.2	46.5	60.1
Shares, diluted (weighted)	25.4	25	30	34.9	41.6	43.3	44.3	45.2	46.5	60.1

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	183	203	142	112	495	503	371	303	159	175
Short-term investments			0	10.3	1.76
Receivables	28.1	30.1	35.9	24.7	22.9	21.2	17.7	19.4	15.8	20.8
Inventory	18.9	13.7	14.1	5.84	6.24	5.14	6.53	13	11.5	5.16
Other current assets	11.7	1.58	2.96	6.2	6.28	5.07	5.47	2.38	1.88	1.49
Total current assets	244	265	215	177	583	552	415	350	228	240
Property, plant and equipment	135	129	135	130	114	109	27	27.6	23.5	13.7
Lease right-of-use assets			0	25.4	17.3	12.6	7.46	3.47	6.86	5.16
Goodwill	14.7	14.7	22.9	27.1	6.16	6.16	6.16	6.16	6.16	6.16
Intangible assets	10.9	7.34	13.4	11.8	14		0.01	25.3	30.2	45.1
Long-term investments	11.8	13	60.4	42	1.41	343	296	156	78.2	66.6
Other non-current assets	14.3	4.22	14.6	4.03	2.65	3.24	2.75	13	29.5	48.6
Total assets	485	434	461	418	830	1,066	879	636	402	425
Accounts payable	106	85.4	103	75.4	110	102	75.1	106	81.9	90
Accrued liabilities	96.2	82.6	87.9	88.2	124	102	63.6	73.7	73.6	51.3
Deferred revenue	41.8	46.5	50.6	41.8	72.2	59.4	44.5	49.6	43.1	34.4
Short-term debt									24.9	15.5
Total current liabilities	249	215	241	216	328	272	191	232	225	192
Long-term debt										0
Lease liabilities			0	21.6	13.2	7.96	3.63	0.94	6.45	5.64
Other non-current liabilities	6.89	7.12	5.96	2.32	4.08	3.3	3.48	9.11	7.91	9.75
Total liabilities	312	262	251	240	394	322	233	277	239	208
Total debt	44.2	0	3.07	0	41.3	38	34.5			0
Paid-in capital	383	495	658	765	971	961	983	1,008	1,073	1,239
Retained earnings	-154	-255	-459	-580	-525	-137	-174	-482	-740	-843
Treasury stock	-52.6	-63.8	-66.8	-68.8	-71.4	-79	-163	-166	-170	-176
Other comprehensive income	-1.54	-0.6	-0.58	-0.57	-0.55	-0.54	-0.52	-0.51	0	-2.57
Shareholders' equity	175	176	132	115	374	744	646	359	163	218
Minority interests	-2.37	-3.51	79	62.8	62.6	0	0		0	0.36
Total equity	173	172	211	178	436	744	646	359	163	218
Total liabilities and equity	485	434	461	418	830	1,066	879	636	402	425
Shares outstanding	25.4	27.5	32.1	39.5	42.8	43	45	45.4	53.1	68.9

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	11.2	-112	-218	-135	46.2	389	-35.2	-308	-259	-84.6
Depreciation and amortization	27.3	28.8	31.7	25.5	21.8	18.6	16.7	19.4	19.1	16.3
Stock-based compensation	4.89	4.08	14.4	16.2	7.84	11.1	18.3	23	19.3	10.9
Deferred income tax	7.72	63.5	-2.23	0.78	-0.02	-53.8	-1.4	41.3	0.28	0.47
Change in receivables	-10	-1.94	-5.56	16.8	-6.72	1.68	3.81	-1.73	3.57	-4.98
Change in inventory	1.11	5.23	0.63	8.27	-0.4	1.11	-1.39	-6.51	1.49	6.38
Change in payables	-18.8	-21	16.5	-26.8	34.4	-7.79	-28.8	32.6	-24.2	8.06
Cash from operations	39.6	-35.2	-139	-81.6	196	80.9	-12.5	-18.6	-174	-56.7
Capital expenditures	-72.3	-23.6	-28.7	-12.8	-14.9	-13.6	-14.9	-19.2	-14.3	-7.41
Acquisitions	1.25	0	-12.9	4.89	0.01
Cash from investing	-79.4	-18	-111	-26.9	-23.6	-86.1	-33	-44.6	24.9	-49.2
Debt issued	36.3	40	0	0	47.5	0	0
Debt repaid	0	-45.8	-40	-3.14	-2.64	-3.03	-3.45	-3.61	-34.8	0
Stock issued	0	0	94.6	83	196	0	0	0	43	137
Share buybacks	0	-10	0	0	0	0	-80.1	0	0	-6.22
Cash from financing	52.7	73.3	189	80.5	231	-10.6	-86.3	-5.49	32.7	122
Net change in cash			-60.9	-27.9	404	-15.8	-132	-68.7	-117	16.1
Free cash flow	-32.7	-58.8	-168	-94.4	182	67.3	-27.4	-37.8	-189	-64.1
Interest paid	1.27	2.94	1.32	0.26	1.81	1.78	1.78	1.6	1.49	1.1
Income taxes paid	1.34	0.49	-0.73	-1.26	1.45	2.26	2.56	0.56	-0.13	-0.38

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $4.35 on August 14, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	25.3%	Gross profit / revenue.
Operating margin	-7.6%	Operating income / revenue.
EBITDA margin	-6.0%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-7.3%	Pre-tax income / revenue.
Net margin	-7.1%	Net income / revenue.
FCF margin	-7.1%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	-6.3%	Cash from operations / revenue.
Return on equity (ROE)	-37.9%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-12.8%	Net income / average total assets.
Return on invested capital (ROIC)	-53.2%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue	0.9%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	0.8%	Capital expenditures / revenue.
D&A / revenue	1.6%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-25.1%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-18.5%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-16.0%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-11.2%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-20.2%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-14.7%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	33.7%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-30.4%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-10.3%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	5.9%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-21.5%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-12.5%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	29.2%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	10.7%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	7.6%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	0.76x	Current assets / current liabilities.
Quick ratio	0.41x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.32x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.06x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	2.1%	Total debt / total assets.
Liabilities / assets	66.1%	Total liabilities / total assets.
Net debt	-$86.0M	Total debt - cash - short-term investments. Negative means more cash than debt.
Working capital	-$74.8M	Current assets - current liabilities.
Goodwill and intangibles / assets	23.4%	(Goodwill + intangible assets) / total assets.
Tangible book value	$66.4M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.80x	Revenue / average total assets.
Fixed asset turnover	26.6x	Revenue / average property, plant and equipment.
Inventory turnover	16.3x	Cost of revenue / average inventory.
Days inventory	22 days	365 x average inventory / cost of revenue.
Receivables turnover	38.2x	Revenue / average receivables.
Days sales outstanding	10 days	365 x average receivables / revenue.
Days payables	60 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	-28 days	Days inventory + days sales outstanding - days payables.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$1.09	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$15.34	Revenue / diluted weighted shares.
FCF per share	-$1.09	Free cash flow / diluted weighted shares.
Operating cash flow per share	-$0.96	Cash from operations / diluted weighted shares.
Book value per share	$2.63	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$0.81	Tangible book value / shares outstanding.
Cash per share	$1.22	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$414.7M	Share price x shares outstanding.
Enterprise value	$328.7M	Market cap + total debt - cash - short-term investments.
P/S	0.36x	Market cap / revenue.
P/B	1.93x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	6.25x	Market cap / tangible book value, when positive.
EV/Sales	0.29x	Enterprise value / revenue.
FCF yield	-19.5%	Free cash flow / market cap.
Earnings yield	-19.6%	Net income / market cap (the inverse of P/E).

What was BED BATH & BEYOND, INC.'s revenue in fiscal 2025?

BED BATH & BEYOND, INC. reported revenue of $1.04B for fiscal 2025, 25.1% lower than the year before.

Was BED BATH & BEYOND, INC. profitable in fiscal 2025?

No. It reported a net loss of $84.6M.

How much free cash flow did BED BATH & BEYOND, INC. generate in fiscal 2025?

Cash from operations of $56.7M minus capital expenditures of $7.4M left free cash flow of -$64.1M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to BED BATH & BEYOND, INC.